246 related articles for article (PubMed ID: 27297951)
1. T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN.
Nosko A; Kluger MA; Diefenhardt P; Melderis S; Wegscheid C; Tiegs G; Stahl RA; Panzer U; Steinmetz OM
J Am Soc Nephrol; 2017 Jan; 28(1):185-196. PubMed ID: 27297951
[TBL] [Abstract][Full Text] [Related]
2. CXCR3+ Regulatory T Cells Control TH1 Responses in Crescentic GN.
Paust HJ; Riedel JH; Krebs CF; Turner JE; Brix SR; Krohn S; Velden J; Wiech T; Kaffke A; Peters A; Bennstein SB; Kapffer S; Meyer-Schwesinger C; Wegscheid C; Tiegs G; Thaiss F; Mittrücker HW; Steinmetz OM; Stahl RA; Panzer U
J Am Soc Nephrol; 2016 Jul; 27(7):1933-42. PubMed ID: 26534920
[TBL] [Abstract][Full Text] [Related]
3.
Berretta F; Piccirillo CA; Stevenson MM
Front Immunol; 2019; 10():425. PubMed ID: 30915078
[TBL] [Abstract][Full Text] [Related]
4. Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy.
Huang CH; Wang CC; Lin YC; Hori M; Jan TR
Int Immunopharmacol; 2017 Jan; 42():59-66. PubMed ID: 27886644
[TBL] [Abstract][Full Text] [Related]
5. IL-10 Receptor Signaling Empowers Regulatory T Cells to Control Th17 Responses and Protect from GN.
Diefenhardt P; Nosko A; Kluger MA; Richter JV; Wegscheid C; Kobayashi Y; Tiegs G; Huber S; Flavell RA; Stahl RAK; Steinmetz OM
J Am Soc Nephrol; 2018 Jul; 29(7):1825-1837. PubMed ID: 29866800
[No Abstract] [Full Text] [Related]
6. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
7. RORγt(+)Foxp3(+) Cells are an Independent Bifunctional Regulatory T Cell Lineage and Mediate Crescentic GN.
Kluger MA; Meyer MC; Nosko A; Goerke B; Luig M; Wegscheid C; Tiegs G; Stahl RA; Panzer U; Steinmetz OM
J Am Soc Nephrol; 2016 Feb; 27(2):454-65. PubMed ID: 26054541
[TBL] [Abstract][Full Text] [Related]
8. Stat3 programs Th17-specific regulatory T cells to control GN.
Kluger MA; Luig M; Wegscheid C; Goerke B; Paust HJ; Brix SR; Yan I; Mittrücker HW; Hagl B; Renner ED; Tiegs G; Wiech T; Stahl RA; Panzer U; Steinmetz OM
J Am Soc Nephrol; 2014 Jun; 25(6):1291-302. PubMed ID: 24511136
[TBL] [Abstract][Full Text] [Related]
9. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
[TBL] [Abstract][Full Text] [Related]
10. The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis.
Neumann K; Ostmann A; Breda PC; Ochel A; Tacke F; Paust HJ; Panzer U; Tiegs G
Sci Rep; 2019 Feb; 9(1):2038. PubMed ID: 30765734
[TBL] [Abstract][Full Text] [Related]
11. CD4
Krebs CF; Steinmetz OM
Mediators Inflamm; 2016; 2016():5393894. PubMed ID: 27974866
[TBL] [Abstract][Full Text] [Related]
12. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
Redjimi N; Raffin C; Raimbaud I; Pignon P; Matsuzaki J; Odunsi K; Valmori D; Ayyoub M
Cancer Res; 2012 Sep; 72(17):4351-60. PubMed ID: 22798340
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of Immune Checkpoint Molecule B and T-Lymphocyte Attenuator Alleviates Experimental Crescentic Glomerulonephritis.
Diefenhardt P; Braumann M; Schömig T; Trinsch B; Sierra Gonzalez C; Becker-Gotot J; Völker LA; Ester L; Mandel AM; Hawiger D; Abdallah AT; Schermer B; Göbel H; Brinkkötter P; Kurts C; Benzing T; Brähler S
J Am Soc Nephrol; 2023 Aug; 34(8):1366-1380. PubMed ID: 37367205
[TBL] [Abstract][Full Text] [Related]
14. The role of Treg subtypes in glomerulonephritis.
Herrnstadt GR; Steinmetz OM
Cell Tissue Res; 2021 Aug; 385(2):293-304. PubMed ID: 33315130
[TBL] [Abstract][Full Text] [Related]
15. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Odobasic D; Jones LK; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2008 Mar; 19(3):477-85. PubMed ID: 18235099
[TBL] [Abstract][Full Text] [Related]
16. A genetic method specifically delineates Th1-type Treg cells and their roles in tumor immunity.
Okamoto M; Sasai M; Kuratani A; Okuzaki D; Arai M; Wing JB; Sakaguchi S; Yamamoto M
Cell Rep; 2023 Jul; 42(7):112813. PubMed ID: 37440410
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor IRF8 controls Th1-like regulatory T-cell function.
Lee W; Kim HS; Baek SY; Lee GR
Cell Mol Immunol; 2016 Nov; 13(6):785-794. PubMed ID: 26166768
[TBL] [Abstract][Full Text] [Related]
18. Stability and function of regulatory T cells expressing the transcription factor T-bet.
Levine AG; Mendoza A; Hemmers S; Moltedo B; Niec RE; Schizas M; Hoyos BE; Putintseva EV; Chaudhry A; Dikiy S; Fujisawa S; Chudakov DM; Treuting PM; Rudensky AY
Nature; 2017 Jun; 546(7658):421-425. PubMed ID: 28607488
[TBL] [Abstract][Full Text] [Related]
19. The Regulatory T-cell Transcription Factor Foxp3 Protects against Crescentic Glomerulonephritis.
Yang C; Huang XR; Fung E; Liu HF; Lan HY
Sci Rep; 2017 May; 7(1):1481. PubMed ID: 28469165
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis.
Paust HJ; Ostmann A; Erhardt A; Turner JE; Velden J; Mittrücker HW; Sparwasser T; Panzer U; Tiegs G
Kidney Int; 2011 Jul; 80(2):154-64. PubMed ID: 21525855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
